Hannah Lu
Impact in
-
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
- Heart Failure Treatment and Management
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Renin-Angiotensin System Studies 3
- Cardiomyopathy and Myosin Studies 1
- Takotsubo Cardiomyopathy and Associated Phenomena 1
-
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Man‐Wai Lo (3 shared papers)Thorir D. Bjornsson (2 shared papers)Christine I. Furtek (2 shared papers)Jacqueline B. McCrea (1 shared paper)Eric W. Tsai (1 shared paper)Dominic P. Ip (1 shared paper)Marvin A. Brooks (1 shared paper)Thomas E. Bradstreet (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (1 paper)Hypertension (1 paper)The Journal of Clinical Pharmacology (1 paper)World Journal of Oncology (1 paper)Journal of Chromatography A (1 paper)
- Partner nations
- United States
In The Last Decade
Hannah Lu
10 papers receiving 420 citations
Peers
Comparison fields: 5 of 56
- Cardiology and Cardiovascular Medicine 228
- Pharmacology 76
- Analytical Chemistry 44
- Pharmaceutical Science 24
- Nephrology 15
Countries citing papers authored by Hannah Lu
This map shows the geographic impact of Hannah Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Lu more than expected).
Fields of papers citing papers by Hannah Lu
This network shows the impact of papers produced by Hannah Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Lu. The network helps show where Hannah Lu may publish in the future.
Co-authors
The 22 scholars most cited alongside Hannah Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 244 | |
| 2 | 1995 | 113 | |
| 3 | 1992 | 49 | |
| 4 | 1998 | 18 | |
| 5 | 2017 | 10 | |
| 6 | 2019 | 10 | |
| 7 | 2017 | 7 | |
| 8 | 2017 | 7 | |
| 9 | 2017 | 2 | |
| 10 | 2021 | 2 |
About Hannah Lu
Hannah Lu is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Nephrology, Ophthalmology and Analytical Chemistry, having authored 10 papers that have together received 462 indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (3 papers), Analytical Methods in Pharmaceuticals (1 paper), Multiple Myeloma Research and Treatments (1 paper), Cardiomyopathy and Myosin Studies (1 paper), Takotsubo Cardiomyopathy and Associated Phenomena (1 paper), Lung Cancer Treatments and Mutations (1 paper), Acute Kidney Injury Research (1 paper) and Pancreatitis Pathology and Treatment (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (228 citations), Pharmacology (76 citations), Analytical Chemistry (44 citations), Pharmaceutical Science (24 citations) and Nephrology (15 citations). Hannah Lu has collaborated with scholars based in United States. Frequent co-authors include Man‐Wai Lo, Thorir D. Bjornsson, Christine I. Furtek, Jacqueline B. McCrea, Eric W. Tsai, Dominic P. Ip, Marvin A. Brooks, Thomas E. Bradstreet, Robert A. Blum and Paul A. Abraham. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Hypertension, The Journal of Clinical Pharmacology, World Journal of Oncology and Journal of Chromatography A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.